Literature DB >> 7608909

[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.

P Traxler1, U Trinks, E Buchdunger, H Mett, T Meyer, M Müller, U Regenass, J Rösel, N Lydon.   

Abstract

[(Alkylamino)methyl]acrylophenones and (alkylamino)propiophenones, bearing a spacer moiety such as the benzyloxy or (benzoylsulfonyl)oxy group in the 4-position, represent a novel class of inhibitors of the epidermal growth factor (EGF) receptor protein tyrosine kinase with a high degree of selectivity versus other tyrosine and serine/threonine kinases. The most active compounds inhibited the EGF receptor protein tyrosine kinase from A431 cell membranes with IC50 values of < 0.5 microM. Derivatives with a benzyloxy substituent in the 4-position of the aromatic ring inhibited both the EGF receptor kinase and the proliferation of an EGF-dependent mouse epidermal keratinocyte cell line (BALB/MK) but were only marginally active in the inhibition of the cellular EGF-dependent tyrosine phosphorylation. Compound 18 inhibited ligand-induced tyrosine phosphorylation and BALB/MK cell proliferation with IC50 values of approximately 100 and 1.21 microM, respectively, and showed antitumor activity in vivo in a nude mouse model. However, the discrepancy between the IC50 values for antiproliferative activity and cellular tyrosine phosphorylation as well as the relatively low tolerability in animals suggests a second site of action of this class of inhibitors. Nevertheless, [(alkylamino)methyl]acrylophenones and (alkylamino)propiophenones may prove to be interesting tools for studying the action of tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608909     DOI: 10.1021/jm00013a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.

Authors:  Carlo Vicentini; Claudio Festuccia; Giovanni Luca Gravina; Adriano Angelucci; Angelo Marronaro; Mauro Bologna
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-04       Impact factor: 4.553

2.  Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.

Authors:  Barbara J Blanchard; Albert Chen; Leslie M Rozeboom; Kate A Stafford; Peter Weigele; Vernon M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-23       Impact factor: 11.205

3.  In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.

Authors:  H L McLeod; V G Brunton; N Eckardt; M J Lear; D J Robins; P Workman; M A Graham
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 4.  Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity.

Authors:  Wiesław Szeja; Grzegorz Grynkiewicz; Aleksandra Rusin
Journal:  Curr Org Chem       Date:  2017-01       Impact factor: 2.180

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.